Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
stratification. In addition to pursuing their own state-of-the-art research programme, the postholder will provide strategic leadership for academic haematology including research, education and mentorship
-
. This is an exciting opportunity to contribute to an innovative programme of research to develop an AI‑enhanced digital tool to support therapy for young people experiencing psychosis or affective disorders
-
wellness experiences that unite our communities and optimise our people and their potential. The post holder will be responsible for coordinating and developing the Resi Sport & Wellness Programme, with a
-
at King's College London. About the role This post focuses on systems immunology approaches to tackle a global healthcare challenge: sepsis. This position forms part of a multidisciplinary programme
-
with King’s Education Strategy. Its portfolio includes flagship Undergraduate and Pre-university Summer Schools, customised undergraduate and postgraduate student programming for international partners
-
and improving research support processes. The Senior Change Manager will work closely with RMID leadership, faculty research support teams, academic researchers, and programme teams to ensure smooth and
-
programme developing an AI‑enhanced digital tool to support cognitive remediation for young people experiencing psychosis or affective disorders. The successful candidate will work under the direct
-
Foundation Programme Grant, we will refine our existing research computational tool and technology into a robust, well-engineering software as a medical device, ready for clinical evaluation. The tool will
-
experience for programme portfolio management in a fast-paced and demanding subject area, and can provide seamless cover over the course of the year. The role is an ideal opportunity for a professional
-
on delivering a high-impact translational research programme that dissects how neuropeptide Y5 receptor (Y5R) signalling in islet-resident immune cells can be harnessed to prevent or delay Type 1 diabetes